• Profile
Close

PROSE offers substantial visual improvement for exposure keratopathy

American Academy of Ophthalmology News Jul 13, 2019

In this retrospective analysis, the authors compared outcomes in patients treated with prosthetic replacement of the ocular surface ecosystem (PROSE) vs other standard-of-care treatments for postsurgical lagophthalmos and exposure keratopathy.

Study design

The authors retrospectively reviewed the charts of 45 patients (53 eyes) with postoperative lagophthalmos and exposure keratopathy. Causes of lagophthalmos included blepharoplasty, ptosis repair, eyelid reconstruction and skull base tumor resection. Visual outcomes were compared between patients who received PROSE (n=22) with those who received standard treatment regimens of lubrication, plugs, and surgery (n=23).

Secondary outcome measures included subjective improvement in vision and comfort and corneal slit-lamp examination findings.

Outcomes

At baseline, visual acuity was significantly poorer in the PROSE vs standard group (0.58 vs. 0.27 logMAR). Patients who received PROSE had greater improvements in visual acuity from baseline (3-lines vs no line) at 1 month after treatment. This improvement was sustained through 12 months. There were no differences in secondary outcome measures between PROSE and standard patients.

Limitations

There was likely significant selection bias, as patients receiving PROSE treatment had significantly more failed treatments than the standard care group (8.3 vs 2.1). Corneal slit lamp examination findings were not quantified.

Clinical significance

This study shows PROSE treatment has utility after oculoplastic surgical procedures that cause lagophthalmos and exposure keratopathy. It may be of particular use in patients with more severe cases of postoperative lagophthalmos and exposure keratopathy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay